Home › Funds › ADAR1 Capital Management, LLC › ZURA

ADAR1 Capital Management, LLC position in ZURA

ZURA BIO · Health Care

ADAR1 Capital Management, LLC reported holding 1,759,295 shares of ZURA (ZURA BIO) in its Q2 2026 13F filing — a position valued at US$10.4M, representing 0.57% of its reported portfolio and ranking #48 among its reported holdings. ADAR1 Capital Management, LLC has disclosed ZURA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)1.76M sh
Reported value held$10.38M
Portfolio Weight0.57%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's ZURA position evolved

ADAR1 Capital Management, LLC first disclosed a stake in ZURA in Q3 2024 at 3,770,649 shares (US$15.3M). Across 8 filings, ADAR1 Capital Management, LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,759,295 shares valued at US$10.4M — an increase of 1,128,892 shares quarter over quarter.. Notable position changes include a 45% trim in Q4 2024 (shares fell 48% over the following quarter), a 64% trim in Q2 2025 (shares rose 312% over the following quarter), a 179% increase in Q2 2026 (shares fell 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 3.77M $15.31M New
Q4 2024 2.08M $5.19M Reduce
Q1 2025 2.80M $3.61M Add
Q2 2025 997.55K $1.05M Reduce
Q3 2025 652.15K $2.82M Reduce
Q4 2025 562.07K $2.95M Reduce
Q1 2026 630.40K $3.75M Add
Q2 2026 1.76M $10.38M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZURA and 13F data

ZURA (ZURA BIO) is a Health Care company. 52 other funds we track also report a position in ZURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$55.7M), Venrock Adviser, LLC (US$38.0M), MPM BioImpact LLC (US$26.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZURA

All ZURA fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held ZURA?

ADAR1 Capital Management, LLC has disclosed ZURA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is ADAR1 Capital Management, LLC's current position in ZURA?

As of Q2 2026, ADAR1 Capital Management, LLC holds 1.76M shares of ZURA (ZURA BIO), valued at $10.38M, representing 0.57% of its reported portfolio and ranking #48.

Has ADAR1 Capital Management, LLC been buying or selling ZURA?

In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC increased its position in ZURA.

Which other funds hold ZURA?

Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, Venrock Adviser, LLC, MPM BioImpact LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.